siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases

• Κύριοι συγγραφείς: Tutu Kalita (Συγγραφέας), Saba Abbasi Dezfouli (Συγγραφέας), Lalit M. Pandey (Συγγραφέας), Hasan Uludag (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2022-11-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

RNAi (RNA interference)-based technology is emerging as a versatile tool which has been widely utilized in the treatment of various diseases. siRNA can alter gene expression by binding to the target mRNA and thereby inhibiting its translation. This remarkable potential of siRNA makes it a useful can...